Search Results - Swathi Ramakrishnan
- Showing 1 - 10 results of 10
-
1
-
2
Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models by Li Shen, Michael J. Ciesielski, Swathi Ramakrishnan, Kiersten Marie Miles, Leigh Ellis, Paula Sotomayor, Protul Shrikant, Robert A. Fenstermaker, Роберто Пили
Published 2012Artigo -
3
Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer by Jason Kirk, Kevin Schaarschuch, Zafardjan Dalimov, Elena Lasorsa, Sheng‐Yu Ku, Swathi Ramakrishnan, Qiang Hu, Gissou Azabdaftari, Jianmin Wang, Роберто Пили, Leigh Ellis
Published 2014Artigo -
4
Combination Strategy Targeting VEGF and HGF/c-met in Human Renal Cell Carcinoma Models by Eric Ciamporcero, Kiersten Marie Miles, Remi Adelaiye‐Ogala, Swathi Ramakrishnan, Li Shen, Sheng‐Yu Ku, Stefania Pizzimenti, Barbara Sennino, Giuseppina Barrera, Роберто Пили
Published 2014Artigo -
5
HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma by Swathi Ramakrishnan, Sheng‐Yu Ku, Eric Ciamporcero, Kiersten Marie Miles, Kristopher Attwood, Sreenivasulu Chintala, Li Shen, Leigh Ellis, Paula Sotomayor, Wendy M. Swetzig, Ray Huang, Dylan Conroy, Ashley Orillion, Gokul M. Das, Роберто Пили
Published 2016Artigo -
6
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage by Eric Ciamporcero, He Shen, Swathi Ramakrishnan, Sheng‐Yu Ku, Sreenivasulu Chintala, Li Shen, Remi Adelaiye‐Ogala, Kiersten Marie Miles, Chiara Ullio, Stefania Pizzimenti, Martina Daga, Gissou Azabdaftari, Kristopher Attwood, Candace S. Johnson, J Zhang, Giuseppina Barrera, Роберто Пили
Published 2015Artigo -
7
Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models by Li Shen, Anette Sundstedt, Michael J. Ciesielski, Kiersten Marie Miles, Mona Celander, Remi Adelaiye‐Ogala, Ashley Orillion, Eric Ciamporcero, Swathi Ramakrishnan, Leigh Ellis, Robert A. Fenstermaker, Scott I. Abrams, Helena Eriksson, Tomas Leanderson, Anders Olsson, Роберто Пили
Published 2014Artigo -
8
Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer by Swathi Ramakrishnan, Victoria Granger, Monika Rak, Qiang Hu, Kristopher Attwood, Lanni Aquila, Nithya Krishnan, Raúl Osiecki, Gissou Azabdaftari, Khurshid A. Guru, Gurkamal Chatta, Geraldine Gueron, Lacey R. McNally, Joyce E. Ohm, Jianmin Wang, Anna Woloszynska‐Read
Published 2019Artigo -
9
Sunitinib Dose Escalation Overcomes Transient Resistance in Clear Cell Renal Cell Carcinoma and Is Associated with Epigenetic Modifications by Remi Adelaiye‐Ogala, Eric Ciamporcero, Kiersten Marie Miles, Paula Sotomayor, Jonathan Bard, Maria Tsompana, Dylan Conroy, Li Shen, Swathi Ramakrishnan, Sheng‐Yu Ku, Ashley Orillion, Joshua Prey, Gerald J. Fetterly, Michael Buck, Sreenivasulu Chintala, Georg A. Bjarnason, Роберто Пили
Published 2014Artigo -
10
Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts by Lei Wei, Sreenivasulu Chintala, Eric Ciamporcero, Swathi Ramakrishnan, May Elbanna, Jianmin Wang, Qiang Hu, Sean T. Glenn, Mitsuko Murakami, Lu Liu, Eduardo Cortes Gomez, Yuchen Sun, Jacob Conroy, Kiersten Marie Miles, Malathi Kullappan, Sudha Ramaiah, Anand Anbarasu, Anna Woloszynska‐Read, Candace S. Johnson, Jeffrey M. Conroy, Song Liu, Carl D. Morrison, Роберто Пили
Published 2016Artigo
Search Tools:
Related Subjects
Cancer research
Biology
Cancer
Medicine
Internal medicine
Biochemistry
Gene
Genetics
Apoptosis
Chemotherapy
Histone
Histone deacetylase
Prostate cancer
Bladder cancer
Cisplatin
Epigenetics
Gene expression
Oncology
Pharmacology
Renal cell carcinoma
Cancer cell
Clear cell renal cell carcinoma
DNA
DNA damage
EZH2
Immune system
Immunology
Immunotherapy
PI3K/AKT/mTOR pathway
Panobinostat